CYTOKINETICS INC — Director's Dealing 2021

Dec 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-12-27

Reporting Person: SMITH SANDFORD D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-27	Common Stock	M	4166	$24.32	Acquired	10931	Direct
2021-12-27	Common Stock	S	4166	$45.79	Disposed	6765	Direct
2021-12-27	Common Stock	M	20000	$21.61	Acquired	26765	Direct
2021-12-27	Common Stock	S	20000	$45.79	Disposed	6765	Direct
2021-12-27	Common Stock	M	4124	$15.43	Acquired	10889	Direct
2021-12-27	Common Stock	S	4124	$45.79	Disposed	6765	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-27	Non-Qualified Stock Option (right to buy)	$15.43	M	4124	Disposed	2030-02-12	Common Stock (4124)	Direct
2021-12-27	Non-Qualified Stock Option (right to buy)	$21.61	M	20000	Disposed	2030-05-13	Common Stock (20000)	Direct
2021-12-27	Non-Qualified Stock Option (right to buy)	$24.32	M	4166	Disposed	2031-05-12	Common Stock (4166)	Direct

Footnotes

F1: Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.